Aastrom(美國)

Aastrom Biosciences

美國AastromBioscienceswww.aastrom.com美國AastromBiosciences,Inc.(NASDAQ:ASTM)專門從事干細胞產(chǎn)品研發(fā)的生物制藥企業(yè)Aastromisaleaderinthedevelopmentofautologouscellproductsfortherepairorregenerationofhumantissue.TheCompany'sp roprietaryTissueRepairCell(TRC)technologyinvolvestheuseofapatient'sowncellstomanufactureproductstotreatarangeofchronicdiseasesandseriousinjuries.Aastrom'sTRC-basedproductscontainincreasednumbersofstemandearlyprogenitorcells,producedfromasmallamountofbonemarrowcollectedfromthepatient.TheTRCtechnologyplatformhaspositionedAastromtoadvancemultipleproductsintoclinicaldevelopment.TheCompany’songoingdevelopmentactivitiesfocusonapplyingTRCtechnologytocardiacandvasculartissueregeneration.APhaseIIclinicaltrialwithdilatedcardiomyopathy(DCM)patients(theIMPACT-DCMtrial)andaPhaseIIbclinicaltrialwithcriticallimbischemia(CLI)patients(theRESTO